TWO DISTINCT PATHWAYS  ·  Non-lyophilized prescription forms are shown in 503A Prescription Care and require clinician review plus a patient-specific prescription. Lyophilized products are shown only in Research Use Only and follow a separate research and compliance review.
NEXTGENLONGEVITY HEALTH
Sign in ℞ / RUO Treatment plan 0
503A PRESCRIPTION + RESEARCH USE ONLY  ·  NGLH INVENTORY-CODED  ·  2026

Two product pathways. One coordinated review.

Every configuration is placed into the correct pathway by dosage form. Solution, tablet/ODT and other non-lyophilized prescription configurations appear in 503A Prescription Care. Lyophilized configurations appear only in Research Use Only. You may select from either or both sections; the complete protocol is submitted together for coordinator review.

66503A configurations
133Research configurations
199Total configurations
1:1Care coordinator

A patient profile is required

The formulary, your treatment plan and protocol status are behind a sign-in. Your profile and health information are stored in the portal database, not in your browser.

Creating a profile does not create a prescription, does not establish that any therapy is medically appropriate, and does not authorize human use of any product designated Research Use Only.